Fourteen Week Clinical Evaluation of an Oral Antioxidant as a Treatment for Osteoarthritis Secondary to Canine Hip Dysplasia

Abstract

(1998). Fourteen Week Clinical Evaluation of an Oral Antioxidant as a Treatment for Osteoarthritis Secondary to Canine Hip Dysplasia. Veterinary Quarterly: Vol. 20, Voorjaarsdagen Congress 1998, pp. S107-S108.